<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="//purl.org/rss/1.0/modules/content/"
	xmlns:wfw="//wellformedweb.org/CommentAPI/"
	xmlns:dc="//purl.org/dc/elements/1.1/"
	xmlns:atom="//www.w3.org/2005/Atom"
	xmlns:sy="//purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="//purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>UM TodayDr. Thomas Mutter &#8211; UM Today</title>
	<atom:link href="https://umtoday-wordpress.ad.umanitoba.ca/tag/dr-thomas-mutter/feed/" rel="self" type="application/rss+xml" />
	<link>https://umtoday-wordpress.ad.umanitoba.ca</link>
	<description>Your Source for University of Manitoba News</description>
	<lastBuildDate>Tue, 27 Jan 2026 15:13:58 +0000</lastBuildDate>
	<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.7.1</generator>
	<item>
		<title>Research pushing the boundaries</title>
        
          <alt_title>
                Research pushing the boundaries 
</alt_title>
        
        
		<link>https://umtoday-wordpress.ad.umanitoba.ca/research-pushing-the-boundaries/</link>
		<comments>https://umtoday-wordpress.ad.umanitoba.ca/research-pushing-the-boundaries/#respond</comments>
		<pubDate>Mon, 13 May 2019 17:30:30 +0000</pubDate>
		<dc:creator><![CDATA[Sean Moore]]></dc:creator>
				<category><![CDATA[Campus News]]></category>
		<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[civil engineering]]></category>
		<category><![CDATA[Dr. Ahmed Ashraf]]></category>
		<category><![CDATA[Dr. Ahmed Shalaby]]></category>
		<category><![CDATA[Dr. Ayesha Saleem]]></category>
		<category><![CDATA[Dr. Hartmut Hollaender]]></category>
		<category><![CDATA[Dr. Kristen Reynolds]]></category>
		<category><![CDATA[Dr. Meaghan Jones]]></category>
		<category><![CDATA[Dr. Natalie Mota]]></category>
		<category><![CDATA[Dr. Pamela Hebbard]]></category>
		<category><![CDATA[Dr. Pooneh Maghoul]]></category>
		<category><![CDATA[Dr. Rakesh Arora]]></category>
		<category><![CDATA[Dr. Renee El-Gabalawy]]></category>
		<category><![CDATA[Dr. Sabine Kuss]]></category>
		<category><![CDATA[Dr. Thomas Mutter]]></category>
		<category><![CDATA[Dr. William Mutch]]></category>
		<category><![CDATA[electrical and computer engineering]]></category>
		<category><![CDATA[Faculty of Science]]></category>
		<category><![CDATA[Kinesiology and Recreation Management]]></category>
		<category><![CDATA[Max Rady College of Medicine]]></category>
		<category><![CDATA[Price Faculty of Engineering]]></category>
		<category><![CDATA[Rady Faculty of Health Sciences]]></category>

		<guid isPermaLink="false">http://news.umanitoba.ca/?p=112446</guid>
		<description><![CDATA[Four early career researchers at the University of Manitoba are among the inaugural recipients of $986,250 in funding from the New Frontiers in Research Fund (NFRF) announced on May 13, 2019, by the Social Sciences and Humanities Research Council (SSHRC). The NFRF program launched in 2018 provides funding that supports high-risk, high-reward and interdisciplinary research [&#8230;]]]></description>
        
        <alt_description><![CDATA[<img width="120" height="90" src="https://umtoday-wordpress.ad.umanitoba.ca/wp-content/uploads/2017/04/Untitled-2-120x90.jpg" class="attachment-newsfeed size-newsfeed wp-post-image" alt="This illustration depicts a three-dimensional (3D) computer-generated image of a number of drug-resistant Neisseria gonorrhoeae diplococcal bacteria. Note that extending from the organisms’ exterior were type IV pili, or hair-like appendages, which in this case, are used to promote motility for these bacteria, and improve surface adherence. The artistic recreation was based upon scanning electron microscopic (SEM) imagery." style="margin-bottom:0px;" decoding="async" srcset="https://umtoday-wordpress.ad.umanitoba.ca/wp-content/uploads/2017/04/Untitled-2-120x90.jpg 120w, https://umtoday-wordpress.ad.umanitoba.ca/wp-content/uploads/2017/04/Untitled-2-800x605.jpg 800w, https://umtoday-wordpress.ad.umanitoba.ca/wp-content/uploads/2017/04/Untitled-2-768x581.jpg 768w, https://umtoday-wordpress.ad.umanitoba.ca/wp-content/uploads/2017/04/Untitled-2-416x315.jpg 416w, https://umtoday-wordpress.ad.umanitoba.ca/wp-content/uploads/2017/04/Untitled-2.jpg 1015w" sizes="(max-width: 120px) 100vw, 120px" /> Early career researchers are among the inaugural recipients of funding from the New Frontiers in Research Fund]]></alt_description>
        
				<content:encoded><![CDATA[<p>Four early career researchers at the University of Manitoba are among the inaugural recipients of $986,250 in funding from the New Frontiers in Research Fund (NFRF) announced on May 13, 2019, by the Social Sciences and Humanities Research Council (SSHRC). The NFRF program launched in 2018 provides funding that supports high-risk, high-reward and interdisciplinary research to help Canadian researchers make the next great discoveries in their fields.</p>
<p>“Traditional parameters are limiting as Canada strives for new discoveries and innovation,” said Ted Hewitt, chair, Canada Research Coordinating Committee and President of SSHRC. “As society evolves, so must our means of doing research. The New Frontiers in Research Fund is supporting leading-edge research and promoting ideas that would have traditionally been unsupported. Through this program, we are truly paving the way for our emerging researchers to expand their horizons, take risks and deliver outcomes that will benefit Canadians.”</p>
<p>The U of M research projects will investigate ways to reverse frailty, allay anxiety using virtual reality, find new antibiotics, and assess the safety of northern infrastructure in the context of climate change. All projects will receive up to $250,000 in funding over two years.</p>
<p>“I congratulate these four early career researchers and their collaborators on their success in this inaugural national competition,” said Digvir Jayas, vice-president (research and international) and Distinguished Professor at the U of M. “They are each pushing the boundaries of existing knowledge and methods as they seek innovative ways to solve problems that affect every member of society.”</p>
<h4>The funded projects are:</h4>
<div id="attachment_112462" style="width: 245px" class="wp-caption alignright"><a href="http://news.umanitoba.ca/wp-content/uploads/2019/05/ayesha_umtoday.jpg"><img fetchpriority="high" decoding="async" aria-describedby="caption-attachment-112462" class=" - Vertical wp-image-112462" src="http://news.umanitoba.ca/wp-content/uploads/2019/05/ayesha_umtoday-250x350.jpg" alt="Ayesha Saleem" width="235" height="329"></a><p id="caption-attachment-112462" class="wp-caption-text">Ayesha Saleem</p></div>
<div id="attachment_112448" style="width: 245px" class="wp-caption alignright"><a href="http://news.umanitoba.ca/wp-content/uploads/2019/05/Meaghan-Jones.png"><img decoding="async" aria-describedby="caption-attachment-112448" class=" - Vertical wp-image-112448" src="http://news.umanitoba.ca/wp-content/uploads/2019/05/Meaghan-Jones-250x350.png" alt="Meaghan Jones" width="235" height="329"></a><p id="caption-attachment-112448" class="wp-caption-text">Meaghan Jones</p></div>
<p><strong>Principle investigators (PI):</strong> Meaghan Jones, biochemistry and medical genetics, Max Rady College of Medicine; and&nbsp;Ayesha Saleem, Faculty of Kinesiology and Recreation Management<br />
<strong>Project:</strong> “Reversing frailty through transmission of epigenetic age by extracellular vesicles.”</p>
<p>The aging population in Canada and around the world requires the development of therapeutic strategies aimed at improving health span (the length of time a person is healthy) to keep pace with the increase in lifespan. In theory, effective anti-aging therapeutics must be capable of altering innate cellular hallmarks of aging such as changes in metabolism and epigenetics. Previous research has shown that transfusing old animals with blood from young animals reverses some aspects of aging, leading to the hypothesis of “youthful” factors in young blood. We propose that these factors are packaged in a type of secretory vehicle called extracellular vesicles (EVs), and that treating old cells with EVs isolated from younger people would reverse physiological markers of aging such as the epigenetic clock and impaired metabolism.</p>
<p>&nbsp;</p>
<div id="attachment_112450" style="width: 260px" class="wp-caption alignright"><a href="http://news.umanitoba.ca/wp-content/uploads/2019/05/Renee-El-Gabalawy.jpg"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-112450" class="size-Medium - Vertical wp-image-112450" src="http://news.umanitoba.ca/wp-content/uploads/2019/05/Renee-El-Gabalawy-250x350.jpg" alt="Renee El-Gabalawy" width="250" height="350"></a><p id="caption-attachment-112450" class="wp-caption-text">Renee El-Gabalawy</p></div>
<p><strong>PI:</strong> Renee El-Gabalawy, anesthesia, Max Rady College of Medicine<br />
<strong>Co-PIs</strong>: Rakesh Arora, Pamela Hebbard, surgery, Max Rady College of Medicine; and fellow Max Rady College of Medicine faculty, Natalie Mota, clinical health psychology; William Mutch, anesthesia; Thomas Mutter, anesthesia; and Kristen Reynolds, psychology, Faculty of Arts.<br />
<strong>Project:</strong> “A targeted preoperative virtual reality intervention with artificial intelligence integration for anxiety in patients undergoing breast cancer surgery.”</p>
<p>Preoperative state anxiety (PSA) occurs in approximately half of breast cancer surgery patients and is associated with several negative mental and physical health postoperative outcomes, which incur costs to both individual patients and the health care system as a whole. Despite this, few targeted and feasible PSA interventions have been developed. The most promising PSA interventions to date involve poorly feasible initiatives where patients are given the opportunity to tour operating rooms (OR) and wards prior to surgery and gain information about the perioperative process in a classroom setting. Immersive virtual reality (VR) is a technologically advanced interface that allows antecedent exposure to simulated stressful environments such as the OR and allows for the integration of interactive artificially intelligent (AI) avatars who can provide information to patients on the perioperative process. We aim to develop and evaluate a novel virtual reality (VR) preoperative intervention with AI avatars to reduce PSA, and mitigate poor postoperative health effects in breast cancer surgery patients</p>
<p>Reducing PSA and preventing poor postoperative outcomes using VR may have significant patient health and financial implications such as reducing levels of acute and chronic postoperative pain and length of stay. This novel research will form the basis of investigating the utility of VR with AI in other surgical cohorts, which may lead to broad implementation of this low cost intervention.</p>
<p>&nbsp;</p>
<div id="attachment_112451" style="width: 260px" class="wp-caption alignright"><a href="http://news.umanitoba.ca/wp-content/uploads/2019/05/Sabine-Kuss.jpg"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-112451" class="size-Medium - Vertical wp-image-112451" src="http://news.umanitoba.ca/wp-content/uploads/2019/05/Sabine-Kuss-250x350.jpg" alt="Sabine Kuss" width="250" height="350"></a><p id="caption-attachment-112451" class="wp-caption-text">Sabine Kuss</p></div>
<p><strong>PI:</strong> Sabine Kuss, chemistry, Faculty of Science<br />
<strong>Title:</strong> “Investigation of antibiotic resistance by electrochemistry.”</p>
<p>Antibiotic resistance has developed into a global problem and has led to a dire need for innovative strategies that are able to quantify efflux and influx of agents into bacterial cells for the assessment of potential new and reliable antimicrobial candidates. The overall goal of the work described in this proposal is the development of an electro-bio-analytical tool that can detect and quantify antibiotic drug resistance and assess newly developed investigational antibacterial therapeutics.</p>
<p>The increase of resistance in Gram-negative bacteria in particular is a major cause for concern, as many Gram-negatives cause serious infections, such as pneumonia, and few antibiotics effective against Gram-negatives have been developed. Studying the influx into and efflux from single bacteria and across populations of antibacterial drugs will provide a numerical quantitative measure for drug resistance leading towards the development of a resistance biosensor. Furthermore, by monitoring the bacterial response time to antibiotics this research will help to better understand resistance adaptation and progression, leading towards the development of new agents and strategies to ultimately overcome drug resistance.</p>
<p>&nbsp;</p>
<div id="attachment_112524" style="width: 245px" class="wp-caption alignright"><a href="http://news.umanitoba.ca/wp-content/uploads/2019/05/ashraf.jpg"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-112524" class=" - Vertical wp-image-112524" src="http://news.umanitoba.ca/wp-content/uploads/2019/05/ashraf-250x350.jpg" alt="Ahmed Ashraf" width="235" height="329"></a><p id="caption-attachment-112524" class="wp-caption-text">Ahmed Ashraf</p></div>
<div id="attachment_112452" style="width: 245px" class="wp-caption alignright"><a href="http://news.umanitoba.ca/wp-content/uploads/2019/05/pooneh1.jpg"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-112452" class=" - Vertical wp-image-112452" src="http://news.umanitoba.ca/wp-content/uploads/2019/05/pooneh1-250x350.jpg" alt="Pooneh Maghoul" width="235" height="329"></a><p id="caption-attachment-112452" class="wp-caption-text">Pooneh Maghoul</p></div>
<p><strong>PI:</strong> Pooneh Maghoul, civil engineering, Faculty of Engineering<br />
<strong>Co-PIs:</strong> Faculty of Engineering &#8211; Ahmed Ashraf, electrical and computer engineering; Hartmut Hollaender, civil engineer; Ahmed Shalaby, civil engineering<br />
<strong>Title:</strong> “Threat assessment for northern civil infrastructure affected by climate change using an AI-based geomechanical model”</p>
<p>Civil infrastructure (roads, dams, etcetera) in Northern Canada was originally designed based on our understanding of frozen soil properties as of the last century, to rely on the properties of ice-rich frozen soil for stability. Climate change has forced us to revisit this understanding. Specifically, in recent years, this infrastructure has been suffering from irregular settlements due to the adverse effects of climate warming, degradation of permafrost, and reduced strength of foundation soils due to thawing. With earth&#8217;s temperature predicted to increase within the lifetime of this infrastructure, structural integrity risks will be further compounded. There is, therefore, an urgent need to develop innovative solutions and strategies that will enable engineers and decision-makers to use these investments for implementing effective, long-term solutions for mitigating adverse impacts of hazards from the effects of climate warming on Canadian infrastructure.</p>
<p>The main objective of this research project is to develop innovative solutions to predict and enhance the structural integrity of existing critical infrastructure as well as future structures built on permafrost areas under different climate warming scenarios. In addition, it is aimed to create a new publicly available portal that will continuously monitor and predict the displacement of critical northern infrastructure subjected to climate warming hazards. This can be achieved by a multidisciplinary research that combines Geo-mechanical and Hydrogeological Modeling, Artificial Intelligence, Deep Learning, and Computer Vision for Remote Sensing, and Asset Management and Life-Cycle Cost Assessment of Climate Change Adaptation Measures as proposed in this study.</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>https://umtoday-wordpress.ad.umanitoba.ca/research-pushing-the-boundaries/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>News Release: Sleep apnea patients can breathe easy</title>
        
          <alt_title>
                 
</alt_title>
        
        
		<link>https://umtoday-wordpress.ad.umanitoba.ca/sleep-apnea-patients-can-breathe-easy/</link>
		<comments>https://umtoday-wordpress.ad.umanitoba.ca/sleep-apnea-patients-can-breathe-easy/#respond</comments>
		<pubDate>Tue, 23 Sep 2014 15:14:37 +0000</pubDate>
		<dc:creator><![CDATA[Sean Moore]]></dc:creator>
				<category><![CDATA[Releases]]></category>
		<category><![CDATA[Dr. Thomas Mutter]]></category>
		<category><![CDATA[Manitoba Centre for Health Policy]]></category>
		<category><![CDATA[Max Rady College of Medicine]]></category>
		<category><![CDATA[Rady Faculty of Health Sciences]]></category>
		<category><![CDATA[Research and International]]></category>

		<guid isPermaLink="false">http://news.umanitoba.ca/?p=15260</guid>
		<description><![CDATA[University of Manitoba-led research has found, for the time, that the risk of serious postoperative cardiovascular complications after surgery could be reduced by more than half if patients with obstructive sleep apnea (OSA) were prescribed treatment with a continuous positive airway pressure (CPAP) device, before their operation. The study, A Matched Cohort Study of Postoperative [&#8230;]]]></description>
        
        <alt_description><![CDATA[ U of M study first to find treatment to reduce surgery complications for a specific type of patient]]></alt_description>
        
				<content:encoded><![CDATA[<p>University of Manitoba-led research has found, for the time, that the risk of serious postoperative cardiovascular complications after surgery could be reduced by more than half if patients with obstructive sleep apnea (OSA) were prescribed treatment with a continuous positive airway pressure (CPAP) device, before their operation.</p>
<p>The study, <em>A Matched Cohort Study of Postoperative Outcomes in Obstructive Sleep Apnea: Could Preoperative Diagnosis and Treatment Prevent Complications</em>,was published today in the October issue of the prestigious journal <a href="http://journals.lww.com/anesthesiology/pages/default.aspx" target="_blank" rel="noopener"><em>Anesthesiology</em></a>, the official medical journal of the American Society of Anesthesiologists.</p>
<p>In light of these findings, appropriate testing for OSA and treatment with a CPAP device, should be considered before patients at risk for OSA undergo surgery, said principal investigator Dr. Thomas Mutter, assistant professor, department of anesthesia and perioperative medicine, College of Medicine, Faculty of Health Sciences, University of Manitoba..</p>
<p>Mutter’s team, along with co-author Dr. Meir Kryger, professor of pulmonary and sleep medicine, Yale School of Medicine, sought to determine what factors affect the risk of serious complications after surgery in patients with obstructive sleep apnea.</p>
<p>Researchers, using data from the<a href="http://umanitoba.ca/faculties/medicine/units/community_health_sciences/departmental_units/mchp/" target="_blank" rel="noopener"> U of M’s Manitoba Centre for Health Policy</a>, compared postoperative outcomes in 4,211 patients diagnosed with OSA, with a matched control group of patients who did not have the condition.&nbsp; Those who were diagnosed with OSA prior to surgery were treated with CPAP therapy.</p>
<blockquote><p>“We found that patients with untreated OSA were at an increased risk of developing cardiovascular complications after surgery, like cardiac arrest and shock,” said Mutter. “However, OSA patients who were diagnosed and prescribed CPAPtherapy before surgery were less than half as likely to develop these same complications.&nbsp; In fact, their risk was similar to patients without OSA.”</p></blockquote>
<p>Furthermore, Mutter’s team found that serious respiratory and cardiovascular complications were increased about two-fold in OSA patients compared to patients without OSA. Increased severity of OSA as well as age, type of surgery and other chronic diseases were also important risk factors in complications.</p>
<p>Obstructive sleep apnea is a common disease, predominantly among men, where patients experience repetitive episodes of airway obstruction during sleep that lead to fragmented, unsatisfying sleep.&nbsp; The main symptoms are loud snoring, pauses in breathing during sleep and excessive sleepiness during the day.</p>
<p>Untreated OSA can also have negative effects on long-term health. OSA is usually treated with a CPAP device, which can improve sleep quality and likely prevent long-term health issues. Diagnosis of OSA requires a sleep study.</p>
<p>Over the past 15 years, Mutter noted, there has been increasing concern that the deleterious effects of anesthetics and surgery on breathing and sleep could be especially risky for patients with obstructive sleep apnea.&nbsp; “This has been of particular concern because as many as 25 per cent of patients presenting for surgery may have OSA.&nbsp; Surprisingly, the vast majority of these patients aren’t treated with CPAP and may not even know they have OSA,” he said.&nbsp; “This study gives us new, important insight as to when treating these patients with CPAP before their operation might make their surgery safer.”</p>
<p>This research was supported by the Manitoba Centre for Health Policy, the National Institutes for Health, and the University of Manitoba.</p>
<p>&nbsp;</p>
<h3>For more information contact Ilana Simon, Director of Communications &amp; Marketing, Faculty of Medicine, University of Manitoba, 204-789-3427, (cell) 204-295-6777 or&nbsp;<a href="mailto:ilana.simon@med.umanitoba.ca" style="display: inline;">ilana.simon@med.umanitoba.ca</a></h3>
<p>&nbsp;</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>https://umtoday-wordpress.ad.umanitoba.ca/sleep-apnea-patients-can-breathe-easy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
